The impact of EndoPredict ® on decision making with increasing oncological work experience: can overtreatment be avoided?-Reference-Cited by-同舟云学术

The impact of EndoPredict ® on decision making with increasing oncological work experience: can overtreatment be avoided?

Published:2019-02-19 Issue:5 Volume:299 Page:1437-1442
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Thangarajah Fabinshy^ORCID,Eichler Christian,Fromme Julia,Malter Wolfram,Caroline Radosa Julia,Ludwig Sebastian,Puppe Julian,Paepke Stefan,Warm Matthias

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/article/10.1007/s00404-019-05097-w/fulltext.html

Reference23 articles.

1. Liedtke C, Jackisch C, Thill M et al (2018) AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2018. Breast Care 13:196–208. https://doi.org/10.1159/000489329

2. Sparano JA, Zhao F, Martino S et al (2015) Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer. J Clin Oncol 33:2353–2360. https://doi.org/10.1200/JCO.2015.60.9271

3. Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319–1329. https://doi.org/10.1093/annonc/mdp322

4. Mokbel K, Wazir U, Wazir A et al (2018) The impact of endopredict clinical score on chemotherapy recommendations in women with invasive ER+/HER2- breast cancer stratified as having moderate or poor prognosis by nottingham prognostic index. Anticancer Res 38:4747–4752. https://doi.org/10.21873/anticanres.12782

5. Perou CM, Sørlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752. https://doi.org/10.1038/35021093

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer;Journal of Personalized Medicine;2021-06-29

2. RNA-in-situ-Hybridisierung: Technologie, Möglichkeiten und Anwendungsbereiche;Der Pathologe;2020-09-30

3. Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14);The Breast;2020-02

4. Genomic Signatures in Luminal Breast Cancer;Breast Care;2020

5. gamma-H2AX: A potential biomarker in breast cancer;Tumor Biology;2019-09